logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Flunarizine Dihydrochloride CAS 30484-77-6

Flunarizine Dihydrochloride CAS 30484-77-6

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 30484-77-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
30484-77-6
Appearance::
White Crystalline Powder, Odorless And Tasteless
Molecular Formula::
C26H28Cl2F2N2
Molecular Weight::
477.41700
EINECS NO::
250-216-6
MDL NO::
MFCD00058198
CAS NO::
30484-77-6
Appearance::
White Crystalline Powder, Odorless And Tasteless
Molecular Formula::
C26H28Cl2F2N2
Molecular Weight::
477.41700
EINECS NO::
250-216-6
MDL NO::
MFCD00058198
Flunarizine Dihydrochloride CAS 30484-77-6

Product Description:

Product Name: Flunarizine dihydrochloride CAS NO: 30484-77-6

 

 

Synonyms:

Flunarizine dihydrochloride,1-[Bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine dihydrochloride;

Flunarizine-d8 dihydrochloride;

1-[Bis(4-fluorophenyl)Methyl]-4-[(2E)-3-phenyl-2-propen-1-yl]piperazine Hydrochloride;

 

 

Chemical & Physical Properties:

Appearance: White crystalline powder, odorless and tasteless

Assay :≥99.0%

Boiling Point: 511.3℃ at 760 mmHg

Melting Point: 204-210℃

Flash Point: 263℃

Storage Condition: 2-8℃

 

 

Safety Information:

RTECS: TK9187000

HS Code: 2933599090

WGK Germany: 3

Risk Statement: R22

Hazard Code: Xn

Signal Word: Warning

Hazard Declaration: H302

Symbol: GHS07

 

 

Calcium channel blocker; fluorinated derivative of Cinnarizine. Vasodilator (cerebral and peripheral). Flunarizine is a selective calcium entry blocker.Target: Calcium ChannelFlunarizine is a drug classified as a calcium channel blocker. Flunarizine is a non-selective calcium entry blocker with other actions including histamine H1 receptor blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. It may help to reduce the severity and duration of attacks of paralysis associated with the more serious form of alternating hemiplegia, as well as being effective in rapid onset dystonia-parkinsonism (RDP). From Wikipedia.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.